Will the HIV AGT103-T Phase 1 study results be released?

The phase 1 trial is done in collaboration with regulatory bodies, laboratory agencies, and independent trial sites. As a collaborative effort, the trial's timeline is not solely under AGT's influence and we cannot give a clear prediction of when the results will be ready. However, we are very close, and the first infusion should occur soon. From there, we will study the trial participants who received AGT103-T to gather data on its safety and release the results of the trial when it is clear how AGT103-T affects the participants. We hope that we will be able to convey some preliminary results to the public this year. 🤞